银屑病严重程度、症状与满意度的患者-皮肤科医生一致性:一项真实世界跨国调查结果
该跨国真实世界调查纳入9个国家524名皮肤科医生与3821例银屑病患者,评估医患对疾病严重程度、症状及控制满意度的看法一致性。严重程度一致性为一般(诊断时61%一致,κ=0.326;调查时55%一致,κ=0.370),症状一致性为一般至中等(κ=0.241-0.575),满意度一致性为一般(39%一致,κ=0.213),各国模式不同但满意度一致性均低。
要点
- 医患对银屑病严重程度判断一致性为一般(诊断时κ=0.326,调查时κ=0.370)。
- 症状一致性为一般至中等(κ=0.241-0.575),满意度一致性为一般(κ=0.213)。
- 各国一致性模式不同,但满意度低一致性在所有国家均观察到。
核心结论
- 这项跨国真实世界调查表明,银屑病患者与其皮肤科医生对疾病严重程度、症状和疾病控制的看法存在差异。
研究设计与样本
- 采用GfK Disease Atlas真实世界证据项目的回顾性横断面调查数据,覆盖9个国家,纳入皮肤科医生及其符合系统治疗条件的银屑病患者。
- 共纳入524名皮肤科医生和3821例银屑病患者,通过患者与医生对相同调查问题的相同回答来测量一致性。
- 一致性采用医生与患者之间的百分比一致率和Cohen kappa(κ)统计量评估,总体及各国分别分析。
主要发现
- 患者与医生对银屑病严重程度的感知一致性在诊断时为一般(61%一致,κ=0.326),在调查时为一般(55%一致,κ=0.370)。
- 当患者采用研究者总体评估/医师总体评估(IGA/PGA)5分量表评分为3或4分(中重度)时,一致性水平更高。
- 症状一致性范围为一般至中等(κ=0.241-0.575)。
- 对银屑病控制满意度的一致性为一般(39%一致,κ=0.213)。
- 各国一致性模式不同,但满意度低一致性在所有参与国家均观察到。
关键数值与推荐
- 一致性等级定义:无(κ≤0)、无至轻微(0.01-0.20)、一般(0.21-0.40)、中等(0.41-0.60)、实质(0.61-0.80)、几乎完美(>0.8)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Psoriasis is a chronic immune-mediated inflammatory disease, which often requires lifelong treatment. A strong partnership between the patient and healthcare practitioners should help to achieve effective treatment outcomes. OBJECTIVE: To assess concordance of views between patients with psoriasis and their treating dermatologists relative to psoriasis severity, presence of symptoms and satisfaction with disease control achieved. METHODS: We used data from the Growth from Knowledge (GfK) Disease Atlas real-world evidence program, a syndicated, retrospective, cross-sectional survey among dermatologists and their systemic therapy eligible patients with psoriasis, conducted across nine countries. Concordance was measured through patients and their dermatologist's identical answers to the same survey questions. Concordance was evaluated using percentage agreement between dermatologists and their patients, and Cohen's kappa (κ) statistic. The level of concordance was defined as 'none' (κ ≤ 0), 'none to slight' (0.01-0.20), 'fair' (0.21-0.40), 'moderate' (0.41-0.60), 'substantial' (0.61-0.80) and 'almost perfect' (>0.8). The analysis was conducted for the overall population and for each participating country. RESULTS: Overall, 524 dermatologists and 3821 patients with psoriasis were included in the survey. Concordance of patient and dermatologist perceptions of psoriasis severity was fair both at diagnosis, and at the time of the survey (61% agreement, κ = 0.326 and 55% agreement, κ = 0.370, respectively). Higher levels of concordance were reported when patients assessed their psoriasis as moderate-to-severe (using Investigator's Global Assessment/Physician's Global Assessment [IGA/PGA] 5-point scale of 3 or 4). Concordance regarding symptoms ranged from fair to moderate (κ = 0.241-0.575). Satisfaction with psoriasis control was fair (39% agreement, κ = 0.213). Results showed different patterns of concordance across the participating countries although a low concordance was observed on the satisfaction with psoriasis control in all of them. CONCLUSION: Results from this multinational real-world survey indicate different perceptions between patients with psoriasis and their dermatologist with respect to psoriasis severity, symptoms and disease control.
引用
- Griffiths CEM, Augustin M, Naldi L, et al. Patient-dermatologist agreement in psoriasis severity, symptoms and satisfaction: results from a real-world multinational survey. J Eur Acad Dermatol Venereol. 2018. PMID: 29524271. doi:10.1111/jdv.14937
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。